AI drug discovery
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
ProPhet's aim is to bring down the time and cost of finding molecules for new drug targets.
AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
EvolutionaryScale's biology-focused language models for drug discovery and therapeutic development will be available to AWS customers.
Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.
The Israel-based company is the result of AION Labs' fifth startup challenge.
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.